Literature DB >> 33479488

Refractory full thickness macular hole: current surgical management.

Rino Frisina1, Irene Gius2, Luigi Tozzi2, Edoardo Midena2.   

Abstract

This review aims to collect the proposed surgical techniques for treating full thickness macular hole (FTMH) refractory to pars plana vitrectomy and internal limiting membrane (ILM) peeling and to analyse and compare anatomical and functional outcomes in order to evaluate their efficacy. The articles were grouped according to the surgical techniques used. Refractory FTMH closure rate and best-corrected visual acuity (BCVA) gain were the two analysed parameters. Thirty-six articles were selected. Ten surgical technique subgroups were defined: autologous platelet concentrate (APC); lens capsular flap transplantation (LCFT); autologous free ILM flap transplantation (free ILM flap); enlargement of ILM peeling, macular hole hydrodissection (MHH), autologous retinal graft (ARG), silicon oil (SO), human amniotic membrane (hAM), perifoveal relaxing retinotomy, arcuate temporal retinotomy. Refractory FTMH closure rate was similar among subgroups, not significant heterogeneity emerged (p = 0.176). BCVA gain showed a significant dependence on surgical technique (p < 0.0001), significant heterogeneity among subgroups emerged (p < 0.0001). Three sets of surgical technique subgroups with a homogeneous BCVA gain were defined: high BCVA gain (hAM); intermediate BCVA gain (APC, ARG, LCFT, MHH, SO); low BCVA gain (free ILM flap, enlargement of peeling, arcuate temporal retinotomy). In terms of visual recovery, the most efficient technique for treating refractory FTMH is hAM, lens capsular flap and APC that allow to obtain better functional outcomes than free ILM flap. MHH, ARG, perifoveal relaxing and arcuate temporal retinotomy require complex and unjustified surgical manoeuvres in view of the surgical alternatives with overlapping anatomical and functional results.
© 2020. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Mesh:

Year:  2021        PMID: 33479488      PMCID: PMC9232562          DOI: 10.1038/s41433-020-01330-y

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


  92 in total

1.  Ethnic variation in primary idiopathic macular hole surgery.

Authors:  A Chandra; M Lai; D Mitry; P J Banerjee; H Flayeh; G Negretti; N Kumar; L Wickham
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

2.  Vitreous surgery with and without internal limiting membrane peeling for macular hole repair.

Authors:  Kazuyuki Kumagai; Mariko Furukawa; Nobuchika Ogino; Akinori Uemura; Seiji Demizu; Eric Larson
Journal:  Retina       Date:  2004-10       Impact factor: 4.256

3.  Internal Limiting Membrane Transposition for Persistent Macular Holes Using Double Layers of Viscoelastic.

Authors:  Mohamed Kamel Soliman; Alexander J Lingley; Yuki Morizane; Raman Tuli
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-06-01       Impact factor: 1.300

4.  Optical coherence tomography of successfully repaired idiopathic macular holes.

Authors:  M Imai; H Iijima; T Gotoh; S Tsukahara
Journal:  Am J Ophthalmol       Date:  1999-11       Impact factor: 5.258

5.  MACULAR HOLE HYDRODISSECTION: Surgical Technique for the Treatment of Persistent, Chronic, and Large Macular Holes.

Authors:  Tina Felfeli; Efrem D Mandelcorn
Journal:  Retina       Date:  2019-04       Impact factor: 4.256

6.  Internal limiting membrane transplantation for unclosed and large macular holes.

Authors:  Yining Dai; Fangtian Dong; Xiao Zhang; Zhikun Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-12       Impact factor: 3.117

7.  Types of macular hole closure and their clinical implications.

Authors:  S W Kang; K Ahn; D-I Ham
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

8.  United Kingdom National Ophthalmology Database study of vitreoretinal surgery: report 2, macular hole.

Authors:  Timothy L Jackson; Paul H J Donachie; John M Sparrow; Robert L Johnston
Journal:  Ophthalmology       Date:  2012-12-01       Impact factor: 12.079

9.  Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study.

Authors:  B M Glaser; R G Michels; B D Kuppermann; R N Sjaarda; R A Pena
Journal:  Ophthalmology       Date:  1992-07       Impact factor: 12.079

10.  Management of Stage IV Macular Holes: When Standard Surgery Fails.

Authors:  R Reis; N Ferreira; A Meireles
Journal:  Case Rep Ophthalmol       Date:  2012-08-08
View more
  5 in total

1.  Comparison of outcomes of idiopathic macular holes treated by vitrectomy with air or silicone oil tamponade based on the hole size.

Authors:  Lan Yin; An-Qi Liu; Xin Jin; Liang Jia; Feng-Xiang Wang
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

Review 2.  Macular Holes: Main Clinical Presentations, Diagnosis, and Therapies.

Authors:  Elias Premi; Simone Donati; Lorenzo Azzi; Giovanni Porta; Cristian Metrangolo; Liviana Fontanel; Francesco Morescalchi; Claudio Azzolini
Journal:  J Ophthalmol       Date:  2022-04-11       Impact factor: 1.974

Review 3.  Update on surgical management of complex macular holes: a review.

Authors:  Mohd-Asyraaf Abdul-Kadir; Lik Thai Lim
Journal:  Int J Retina Vitreous       Date:  2021-12-20

4.  Postoperative retinal microstructure and functional outcome after inverted-flap technique associated with silicone oil tamponade in macular hole surgery.

Authors:  Christiana Diana Maria Dragosloveanu; Nicoleta Zamfiroiu-Avidis; Şerban Dragosloveanu; Mihai Adrian Păsărică; Cătălina Ioana Tătaru; Paul Filip Curcă
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

5.  Human Platelets Take up Anti-VEGF Agents.

Authors:  B Sobolewska; B Fehrenbacher; P Münzer; H Kalbacher; S Geue; Konstantinos Stellos; M Schaller; F Ziemssen
Journal:  J Ophthalmol       Date:  2021-06-14       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.